These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38172380)

  • 1. Late-onset multiple sclerosis: disability trajectories in relapsing-remitting patients of the Italian MS Registry.
    Lorefice L; Ferraro OE; Fenu G; Amato MP; Bresciamorra V; Conte A; De Luca G; Ferraro D; Filippi M; Gazzola P; Iaffaldano P; Inglese M; Lus G; Marfia GA; Patti F; Pesci I; Salemi G; Trojano M; Zaffaroni M; Monti MC; Cocco E;
    J Neurol; 2024 Apr; 271(4):1630-1637. PubMed ID: 38172380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disability trajectories by progression independent of relapse activity status differ in pediatric, adult and late-onset multiple sclerosis.
    Simone M; Lucisano G; Guerra T; Paolicelli D; Rocca MA; Brescia Morra V; Patti F; Annovazzi P; Gasperini C; De Luca G; Ferraro D; Margari L; Granella F; Pozzilli C; Romano S; Perini P; Bergamaschi R; Coniglio MG; Lus G; Vianello M; Lugaresi A; Portaccio E; Filippi M; Amato MP; Iaffaldano P;
    J Neurol; 2024 Oct; 271(10):6782-6790. PubMed ID: 39179712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis.
    Mirmosayyeb O; Brand S; Barzegar M; Afshari-Safavi A; Nehzat N; Shaygannejad V; Sadeghi Bahmani D
    J Clin Med; 2020 May; 9(5):. PubMed ID: 32370288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Older Age at Multiple Sclerosis Onset Is an Independent Factor of Poor Prognosis: A Population-Based Cohort Study.
    Guillemin F; Baumann C; Epstein J; Kerschen P; Garot T; Mathey G; Debouverie M;
    Neuroepidemiology; 2017; 48(3-4):179-187. PubMed ID: 28793296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a late-onset multiple sclerosis Portuguese cohort.
    Moura J; Duarte S; Oliveira V; Pereira D; Costa D; Samões R; Sousa AP; Silva AM; Santos E
    Mult Scler Relat Disord; 2023 Feb; 70():104506. PubMed ID: 36638770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of cognitive and physical characteristics in late-onset, adult-onset and early-onset multiple sclerosis patients.
    Ozakbas S; Kaya E; Aslan T; Ozdogar AT; Baba C
    Mult Scler Relat Disord; 2024 Oct; 90():105810. PubMed ID: 39180837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register.
    Lepore V; Bosetti C; Santucci C; Iaffaldano P; Trojano M; Mosconi P;
    Eur J Neurol; 2021 Feb; 28(2):567-578. PubMed ID: 33058344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling disease progression in relapsing-remitting onset multiple sclerosis using multilevel models applied to longitudinal data from two natural history cohorts and one treated cohort.
    Tilling K; Lawton M; Robertson N; Tremlett H; Zhu F; Harding K; Oger J; Ben-Shlomo Y
    Health Technol Assess; 2016 Oct; 20(81):1-48. PubMed ID: 27817792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and demographic characteristics of late-onset multiple sclerosis: LOMS-TR study.
    Sıvacı AÖ; Seferoğlu M; Piri Çınar B; Uzunköprü C; Beckmann Y; Güngör Doğan İ; Çetinkaya Tezer D; Tunç A; Ethemoğlu Ö; Gümüş H; Açıkgöz M; Yalaz Tekan Ü; Demir S
    Mult Scler Relat Disord; 2024 Apr; 84():105469. PubMed ID: 38341979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries.
    Sharmin S; Roos I; Malpas CB; Iaffaldano P; Simone M; Filippi M; Kubala Havrdova E; Ozakbas S; Brescia Morra V; Alroughani R; Zaffaroni M; Patti F; Eichau S; Salemi G; Di Sapio A; Inglese M; Portaccio E; Trojano M; Amato MP; Kalincik T; ;
    Lancet Child Adolesc Health; 2024 May; 8(5):348-357. PubMed ID: 38547883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Time to Reach EDSS 6.0 Faster in Patients with Late-Onset versus Young-Onset Multiple Sclerosis?
    Alroughani R; Akhtar S; Ahmed S; Behbehani R; Al-Hashel J
    PLoS One; 2016; 11(11):e0165846. PubMed ID: 27802328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is late-onset multiple sclerosis associated with a worse outcome?
    Tremlett H; Devonshire V
    Neurology; 2006 Sep; 67(6):954-9. PubMed ID: 17000960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early onset multiple sclerosis and the effect of disease onset age on neurological disability in multiple sclerosis.
    Usta NC; Boz C; Terzi M
    Clin Neurol Neurosurg; 2023 Jan; 224():107528. PubMed ID: 36446265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late-onset MS is associated with an increased rate of reaching disability milestones.
    Andersen MA; Buron MD; Magyari M
    J Neurol; 2021 Sep; 268(9):3352-3360. PubMed ID: 33677675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal follow-up of "benign" multiple sclerosis at 20 years.
    Sayao AL; Devonshire V; Tremlett H
    Neurology; 2007 Feb; 68(7):496-500. PubMed ID: 17296915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late-onset multiple sclerosis in Iran: A report on demographic and disease characteristics.
    Ghadiri F; Sahraian MA; Razazian N; Ashtari F; Poursadeghfard M; Nabavi SM; Navardi S; Baghbanian SM; Shaygannejad V; Harirchian MH; Beladimoghadam N; Majdinasab N; Hosseini S; Azimi A; Kamali H; Sharifipour E; Hosseini Nejad Mir N; Bayati A; Nahayati MA; Heidari H; Mozhdehipanah H; Ghalyanchi Langroodi H; Jalali N; Ayoubi S; Asadollahzadeh E; Ebadi Z; Eskandarieh S; Naser Moghadasi A
    Mult Scler Relat Disord; 2023 Feb; 70():104493. PubMed ID: 36638768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Features of Late-Onset Multiple Sclerosis: a Systematic Review and Meta-analysis.
    Naseri A; Nasiri E; Sahraian MA; Daneshvar S; Talebi M
    Mult Scler Relat Disord; 2021 May; 50():102816. PubMed ID: 33571792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Characteristics and Long-Term Outcomes of Late-Onset Multiple Sclerosis: A Swedish Nationwide Study.
    Mouresan EF; Mentesidou E; Berglund A; McKay KA; Hillert J; Iacobaeus E
    Neurology; 2024 Mar; 102(6):e208051. PubMed ID: 38394472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up study.
    D'Amico E; Patti F; Zanghì A; Chisari CG; Lo Fermo S; Zappia M
    Eur J Neurol; 2018 Dec; 25(12):1425-1431. PubMed ID: 29956427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.